A California nonprofit, 501(c)(3) status pending — we're inviting founding foundation partners and supporters to build with us.


Medication-safety program

Clean Meds Finder

A medication-safety program for people who react to what's inside their medicine. Find treatments free of the inactive ingredients that trigger reactions — in seconds, not hours of label-reading.

In beta · free to try

A search surfacing a tolerable clean-match result and excluding an unsafe one

See it for yourself

The beta is live.

Search a medication, tell it the ingredients you need to avoid, and watch the clean matches surface in seconds. It's free — you'll search as a guest, with no account to create — and we'd love your feedback.

Demo the tool

Opens in a new tab · for informational purposes only, not medical advice

FAQ  ·  Privacy Policy

What it does

The manual DailyMed review clinicians recommend — done instantly.

Specialists tell sensitive patients to check the FDA's drug labels before every refill and keep a list of tolerated formulations. Clean Meds Finder does that across the whole database in one search.

Search by excipient, instantly

DailyMed isn't searchable by ingredient. Clean Meds Finder is: name a drug, choose the excipient categories you must avoid — dyes, lactose, alcohols, PEG — and see the formulations that leave them out in seconds.

Catches what DailyMed misses

DailyMed's own labels are often inconsistent about inactive ingredients. Clean Meds Finder surfaces every reference to an excipient — even when it's miscategorized or mislabeled — closing the gaps Kinsella's 2024 audit documented.

No account, no PHI

Search as a guest — no account to create — and running a search collects no protected health information.

Where it came from

Built from real research — and real need.

The research it stands on

Clean Meds Finder is built directly on the work of the clinicians and researchers who documented this problem, and we're grateful for it:

  • Dr. Jill Schofield and Dr. Lawrence Afrin — whose 2019 study of medication excipient reactivity in mast cell activation syndrome showed how often the "inactive" ingredients are the true cause, and urged patients to review the FDA's DailyMed labels before every refill.
  • Laurence Kinsella, Jill Brook, Mike Brook, and Michelle Briest — whose 2024 audit found that those same DailyMed listings are internally inconsistent in a striking share of common medications. Clean Meds Finder is built to catch exactly those errors.

Also personal

Clean Meds Finder is the tool our founder, Gabe, wished he'd had. Vetting medications for his child, he could use DailyMed — but it isn't searchable by ingredient, so every lookup meant opening and reading dozens of separate drug labels, one at a time. Once we understood how much excipient reactivity was driving reactions and began screening every medication for the ingredients to avoid, our own hospitalizations and ER visits dropped. Clean Meds Finder does that screening in seconds, and catches the labeling inconsistencies that made the manual process unreliable.

From their findings to everyday help. Clean Meds Finder performs the DailyMed review Schofield and Afrin recommend — instantly, across the whole database — and actively closes the label-inconsistency gaps the Kinsella and Brook team documented: it surfaces references to an excipient even when DailyMed miscategorizes or mislabels it.

Why it matters

Excipient reactivity can be dangerous — not just uncomfortable.

For people with mast cell activation syndrome and related disorders, a reaction to an "inactive" ingredient can escalate to a severe, even anaphylactic, event — and a trip to the emergency room. Screening those ingredients out of a medication is a safety measure, not a convenience.

Dyes & alcoholsthe most common excipient triggers in mast cell activation syndrome1
39%of common drug listings had inconsistent excipient data2
55%of drugs contain at least one FODMAP sugar; ~1 in 5 contain gluten3

1. Schofield & Afrin, Am J Med Sci 2019. 2. Kinsella, Brook, Briest & Brook, Naunyn-Schmiedeberg's Arch Pharmacol 2024. 3. Reker et al. (cited in Kinsella 2024), Sci Transl Med 2019.

Reporting & visibility

You see exactly how the program is doing.

Every partner gets a live dashboard and quarterly impact reports, so you can confirm the program is meeting your community's needs — and prove it to your board and funders. We report what we can honestly stand behind, and never claim what we can't.

Sample quarterly impact report

Illustrative · sample figures
1,240
Patients reached
5,600
Searches run
78%
Searches with a clean match
22k
Medications reviewed

Searches by month (sample)

JanFebMarAprMayJun

Real dashboards are tailored to your mission's metrics — we report against the outcomes you care about.